Abstract
Secondary infections with Staphylococcus aureus (i.e. impetiginization) are common in patients with atopic dermatitis (AD). However, a scale to assess the severity of impetiginization is lacking. This study aimed to develop and investigate an Investigator Global Assessment (IGA) for impetiginization in AD (‘IGA impetiginization’). Consensus was achieved for a 3-point IGA scale containing a description of clinical signs and extent of the affected area. Substantial inter-rater reliability [intraclass correlation coefficient (ICC) 0.68], good intra-rater reliability (ICC 0.81) and good overall agreement (81%) were found. The IGA impetiginization is a simple scale for the assessment of impetiginization in AD that could be used in clinical practice and research.
Funding Information
  • Netherlands Organisation for Health Research and Development (843004017)